Neurodegenerative Diseases: current treatment algorithm and potential investment opportunities covered in a lates research report

This report examines the entire neurodegenerative disease therapy area, with a particular focus on the three most prevalent neurodegenerative disorders: Alzheimer’s disease (AD), Parkinson’s disease (PD) and multiple sclerosis (MS).

Pune, India - March 14, 2018 /MarketersMedia/ —

AD and PD represent the most pressing challenges within the disease cluster, due to rapidly increasing prevalence driven by aging populations. Both AD and PD remain ineffectively treated despite substantial investment into R&D by pharmaceutical companies, due to high clinical trial failure rates. As a result there are no disease-modifying therapies for these two indications, with available treatments able to provide only marginal symptomatic relief. MS, the autoimmune disease of the CNS, contrasts with the rest of this cluster, as it affects a different population demographic, and has a lucrative pharmacological market following breakthrough success in the past decade.
Access Report Details at: https://www.themarketreports.com/report/frontier-pharma-neurodegenerative-diseases-protein-misfolding-targets-and-neuromodulators-dominate-the-first-in-class-pipeline-and-lead-the-way-as-potential-disease-modifying-therapies-in-ad-and-pd
Reasons To Buy
• Appreciate the current clinical and commercial landscapes by considering disease symptoms, pathogenesis, etiology, co-morbidities and complications, epidemiology, diagnosis, prognosis and treatment options.
• Identify leading products and key unmet needs within the market.
• Recognize innovative pipeline trends by analyzing therapies by stage of development, molecule type and molecular target.
• Assess the therapeutic potential of first-in-class targets. Using proprietary matrix assessments, first-in-class targets in the pipeline have been assessed and ranked according to clinical potential. Individual matrix assessments are provided for targets categorized into four major classes: protein misfolding, neuromodulators, immunomodulators and neuroprotectants. The most promising first-in-class targets are reviewed in greater detail.
• Consider first-in-class pipeline products with no prior involvement in licensing and co-development deals, which may represent potential investment opportunities.
Get this report at: https://www.themarketreports.com/report/buy-now/935553
Scope
• Unmet need is extremely high in AD and PD, with MS showing continued promise in the development of effective therapies
• What are the most important etiological risk factors and pathophysiological processes implicated in AD, PD and MS?
• What is the current treatment algorithm?
• How effective are current therapies for these indications, and how does this impact prognosis?
• The AD pipeline is large and contains a very high proportion of first-in-class product innovation.
• Which molecule types and molecular targets are most prominent across AD, PD and MS?
• What are the connections, in terms of first-in-class innovation, between AD, PD and MS?
• Which first-in-class targets are most promising?
Inquire for more details at: https://www.themarketreports.com/report/ask-your-query/935553

Contact Info:
Name: Shirish Gupta
Email: sales@themarketreports.com
Organization: The Market Reports
Address: SF-29, Sacred World, Wanawadi
Phone: 16314071315

Source URL: https://marketersmedia.com/neurodegenerative-diseases-current-treatment-algorithm-and-potential-investment-opportunities-covered-in-a-lates-research-report/314330

For more information, please visit https://www.themarketreports.com/report/frontier-pharma-neurodegenerative-diseases-protein-misfolding-targets-and-neuromodulators-dominate-the-first-in-class-pipeline-and-lead-the-way-as-potential-disease-modifying-therapies-in-ad-and-pd%20

Source: MarketersMedia

Release ID: 314330

More Press Releases

Global shares rise as traders shrug off new China-US tariffs

Sep 19, 2018

TOKYO — Global shares were mostly higher Wednesday despite jitters over the escalating trade dispute between the U.S. and China. KEEPING SCORE: France's CAC 40 edged up 0.3 percent to 5,380.16, while Germany's DAX gained 0.2 percent to 12,185.36. Britain's FTSE 100 was flat at 7,301.46. U.S. shares were set to rise with Dow futures up 0.1 percent at 26,325. S&P 500 futures were flat at 2,911.80. ASIA'S DAY: Japan's benchmark Nikkei 225 added 1.1 percent to finish at 23,672.52. Australia's S&P/ASX 200 was up 0.5 percent at 6,190.00. South Korea's Kospi was virtually unchanged at 2,308.46. Hong Kong's Hang...

Asian shares rise as traders shrug off new China-US tariffs

Sep 19, 2018

TOKYO — Asian shares were mostly higher Wednesday, despite jitters over the escalating trade dispute between the U.S. and China. KEEPING SCORE: Japan's benchmark Nikkei 225 added 1.4 percent in early trading to 23,741.29. Australia's S&P/ASX 200 rose 0.4 percent to 6,195.70. South Korea's Kospi slipped 0.3 percent to 2,303.34. Hong Kong's Hang Seng advanced 1.0 percent to 27,355.73, while the Shanghai Composite also jumped 1.0 percent, to 2,726.27. TRADE TENSIONS: The administration of President Donald Trump has decided to impose tariffs on an additional $200 billion of Chinese goods. China responded by saying it will go ahead with plans...

The Latest: China's premier appeals for global support

Sep 19, 2018

NEW YORK — The Latest on the U.S.-China trade war (all times local): ___ 11:30 p.m. China's No. 2 leader has appealed for global support for free trade following tit-for-tat U.S. and Chinese tariff hikes in an escalating battle over Beijing's technology policy. Premier Li Keqiang said Wednesday in a speech to a business conference that disputes must be worked out through consultation. China announced a tariff hike on $60 billion of American imports on Tuesday in response to U.S. President Donald Trump's increase on $200 billion of Chinese goods. Speaking at the World Economic Forum in the eastern city...

Venezuela doubles down on Chinese money to reverse crisis

Sep 19, 2018

CARACAS, Venezuela — Venezuelan President Nicolas Maduro said Tuesday that new investments from China will help his country dramatically boost its oil production, doubling down on financing from the Asian nation to turn around its crashing economy. Already a major economic partner, China has agreed to invest $5 billion more in Venezuela, Maduro said following a recent trip to Beijing, adding that the money would help it nearly double its oil exports to China. "We are taking the first steps into a new economic era," he said. "We are on track to have a new economy, and the agreements with...

Markets Right Now: Markets shrug off trade and end higher

Sep 19, 2018

NEW YORK — The latest on developments in financial markets (all times local): 4 p.m. Investors shrugged off the latest escalation of trade tensions between the U.S. and China and sent stocks broadly higher on Wall Street. Major U.S. indexes on Tuesday gained back nearly all the ground they lost the day before. Technology and consumer-focused companies had some of the biggest gains. Chipmaker Micron Technology rose 4.1 percent and Netflix jumped 5 percent. Ferrari rose 4.2 percent after the sportscar maker announced a new lineup of models. The S&P 500 index rose 15 points, or 0.5 percent, to 2,904....

Subscribe to our newsletter!

Your Name

Your Email Address